Stock Events

Stock Events

Corvus Pharmaceuticals (CRVS) Q2 2023 Earnings

8AugConfirmed

Aug 22

Nov 22

Q1 2023

Q2 2023

-0.32

-0.26

-0.2

-0.14

Details

Expected EPS

-0.14

Actual EPS

-0.14

Surprise EPS

0

Surprise Percent

+0%

Description

Corvus Pharmaceuticals (CRVS) has reported earnings of -0.14 per share for Q2 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.